이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Daiken Medical 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Keiichi Yamada

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	20.3yrs
CEO 소유권	20.8%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	4.1yrs

최근 관리 업데이트

Recent updates

CEO

Keiichi Yamada (66 yo)

20.3yrs

테뉴어

Mr. Keiichi Yamada has been the President and Chief Executive Officer at Daiken Medical Co., Ltd. since March 2004 and serves as its General Manager of Technology Division since April 2019 and General Mana...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Keiichi Yamada	President	20.3yrs	데이터 없음	20.75% ¥ 3.3b
Masayuki Yamada	Executive VP	no data	데이터 없음	데이터 없음
Hiroshi Daikuya	Independent Outside Director	8.1yrs	데이터 없음	0.017% ¥ 2.7m
Kenji Mamasaki	Full Time Auditor	3.1yrs	데이터 없음	0.031% ¥ 4.9m
Yoshimi Inagaki	Independent Outside Director	3.1yrs	데이터 없음	데이터 없음
Yuki Onishi	Outside Audit & Supervisory Board Member	4.1yrs	데이터 없음	데이터 없음
Hajime Murakami	Outside Audit & Supervisory Board Member	4.1yrs	데이터 없음	데이터 없음

4.1yrs

평균 재임 기간

63yo

평균 연령

경험이 풍부한 이사회: 7775 의 이사회는 경험(평균 재직 기간 4 년)으로 간주됩니다.

Daiken Medical 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

Insufficient new directors

Daiken Medical Co., Ltd., Annual General Meeting, Jun 20, 2024

Daiken Medical Co., Ltd., Annual General Meeting, Jun 21, 2023

Less than half of directors are independent

Daiken Medical Co., Ltd., Annual General Meeting, Jun 21, 2022

Less than half of directors are independent

Recent updates

Insufficient new directors

Daiken Medical Co., Ltd. to Report Q1, 2025 Results on Jul 31, 2024

Full year 2024 earnings released: EPS: JP¥34.39 (vs JP¥24.78 in FY 2023)

Full year 2024 earnings released: EPS: JP¥34.39 (vs JP¥24.78 in FY 2023)

Daiken Medical Co., Ltd., Annual General Meeting, Jun 20, 2024

Daiken Medical Co., Ltd. to Report Fiscal Year 2024 Results on May 15, 2024

Upcoming dividend of JP¥12.00 per share

Third quarter 2024 earnings released: EPS: JP¥12.22 (vs JP¥9.02 in 3Q 2023)

New minor risk - Market cap size

Daiken Medical Co., Ltd. Announces Dividend for the Second Quarter-End of the Fiscal Year Ending March 31, 2024, Payable on December 1, 2023; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024

Second quarter 2024 earnings released: EPS: JP¥10.20 (vs JP¥7.90 in 2Q 2023)

New minor risk - Market cap size

Upcoming dividend of JP¥9.00 per share at 4.0% yield

First quarter 2024 earnings released: EPS: JP¥8.49 (vs JP¥7.03 in 1Q 2023)

Daiken Medical Co., Ltd. Provides Dividend Guidance for the Second Quarter End and Full Year of 2024

Now 21% undervalued

Full year 2023 earnings released: EPS: JP¥24.78 (vs JP¥28.93 in FY 2022)

Daiken Medical Co., Ltd. to Report Q1, 2024 Results on Jul 31, 2023

Daiken Medical Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Six Months Ending September 30, 2023 and Full Year March 31, 2024

Full year 2023 earnings released: EPS: JP¥24.78 (vs JP¥28.93 in FY 2022)

Daiken Medical Co., Ltd., Annual General Meeting, Jun 21, 2023

Upcoming dividend of JP¥11.00 per share at 3.7% yield

Daiken Medical Co., Ltd. Provides Fiscal Year End Dividend Guidance for the Year Ending March 31, 2023

Third quarter 2023 earnings released: EPS: JP¥9.02 (vs JP¥9.12 in 3Q 2022)

Daiken Medical Co., Ltd. to Report Q3, 2023 Results on Jan 31, 2023

Less than half of directors are independent

Second quarter 2023 earnings released: EPS: JP¥7.90 (vs JP¥7.80 in 2Q 2022)

Daiken Medical Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2023

Daiken Medical Co., Ltd. to Report Q2, 2023 Results on Oct 31, 2022

Upcoming dividend of JP¥9.00 per share

Daiken Medical Co., Ltd. Provides Dividend Guidance for the Second Quarter Ending September 30, 2022 and the Full Year Ending March 31, 2023

First quarter 2023 earnings released: EPS: JP¥7.03 (vs JP¥6.13 in 1Q 2022)

Daiken Medical Co., Ltd. to Report Q1, 2023 Results on Jul 29, 2022

Full year 2022 earnings released: EPS: JP¥28.93 (vs JP¥23.50 in FY 2021)

Full year 2022 earnings released: EPS: JP¥28.93 (vs JP¥23.50 in FY 2021)

Daiken Medical Co., Ltd., Annual General Meeting, Jun 21, 2022

Price target decreased to JP¥600

Less than half of directors are independent

Daiken Medical Co., Ltd. to Report Fiscal Year 2022 Results on May 13, 2022

Upcoming dividend of JP¥11.00 per share

Daiken Medical Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: EPS JP¥7.80 (vs JP¥7.45 in 2Q 2021)

Upcoming dividend of JP¥9.00 per share

Daiken Medical Co., Ltd. Announces Non-Consolidated Earnings Guidance for the Six Months Ending September 30, 2021 and Full Year Ending March 31, 2022

Full year 2021 earnings released: EPS JP¥23.50 (vs JP¥29.90 in FY 2020)

Price target decreased to JP¥700

Daiken Medical Co., Ltd. Announces Non-Consolidated Earnings Guidance for the Six Months Ending September 30, 2021 and Full Year Ending March 31, 2022

Full year 2021 earnings released: EPS JP¥23.50 (vs JP¥29.90 in FY 2020)

Upcoming dividend of JP¥11.00 per share

New 90-day high: JP¥585

Third quarter 2021 earnings released: EPS JP¥9.82 (vs JP¥9.75 in 3Q 2020)

New 90-day high: JP¥579

New 90-day high: JP¥558

Daiken Medical Co., Ltd. to Report Q3, 2021 Results on Jan 29, 2021

Daiken Medical Co., Ltd. to Report Q2, 2021 Results on Oct 30, 2020

CEO

테뉴어

이사회 구성원

평균 재임 기간

평균 연령